Akebia Therapeutics, Inc. (AKBA)
1.625
+0.04
(+2.85%)
USD |
NASDAQ |
Dec 10, 16:00
1.60
-0.02
(-1.54%)
After-Hours: 20:00
Akebia Therapeutics Shareholders Equity (Quarterly): 41.59M for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Pfizer Inc. | 92.80B |
| Plus Therapeutics, Inc. | 5.054M |
| Ironwood Pharmaceuticals, Inc. | -264.16M |
| Pyxis Oncology, Inc. | 68.78M |
| Karyopharm Therapeutics, Inc. | -269.26M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 364.15M |
| Total Liabilities (Quarterly) | 322.56M |
| Debt to Equity Ratio | 5.128 |
| Current Ratio | 1.937 |
| Net Debt Paydown Yield | -3.00% |